-
3 billion, nearly 10 years, why GlaxoSmithKline again?
Violation of the quality of the red line, foreign companies still heavy fines.
2022-11-07 16:46 -
-
Fastest $1 billion ADC drug? Who can fight Enhertu for Breast cancer?
Of the 14 ADC drugs currently on the market, only Seagen/ Takeda's Adcetris and Roche's Kadcyla had global sales of more than $1 billion last year, ac...
2022-11-07 16:46 -
The battle between Pfizer and Gilead over COVID-19 drugs will continue
The oral version of remdesivir, GS-5245, entered phase 3 clinical trials.
2022-11-03 17:28 -
Science: Breakthrough! Chinese researchers have discovered a new target drug for depression that tak...
Novel and rapid antidepressant target discovery.
2022-11-03 17:28 -
Will a new generation of Medicine Kings take over?
The year 2022 May be the last year for Humele to enjoy the status of "medicine king".
2022-11-03 17:28 -
The battle for Medicine King! With the onslaught of K drug and the setback of Xiomele, the biggest v...
With the global MNC giants have announced the Q3 financial results in 2022, from the sales of their blockbuster products, the pharmaceutical industry ...
2022-11-03 17:28 -
JAK inhibitor, the successor to Hummero?
Angel or devil? JAK inhibitors have been a source of controversy.
2022-11-02 15:04 -
Only ten new anticancer drugs targeting Nectin-4 are under clinical research in the world. What are ...
Urothelial carcinoma is a malignant tumor originating from the urinary bladder urothelium. It is one of the most common malignant tumors of the urinar...
2022-11-01 15:13 -
Granja holdings Hengrui 40 million shares
Hengrui Pharmaceutical's revenue has started to grow again after three straight quarters of decline.
2022-11-01 15:13
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
